Saad Gilani

Saad Gilani is a Managing Director at Yorkville Advisors Global and has been with the firm since 2005. As the head of healthcare investments, he has led financing transactions in a variety of life science companies focused on biotechnology, molecular diagnostics, surgical instruments and medical devices in the US and in Europe. Saad is a member of the firm’s Investment Committee.

Prior to joining Yorkville Advisors Global, Saad worked at Keyence Corporation for 11 years where he held various management roles within the Engineering and Marketing groups. Saad earned a B.Sc. in Electrical Engineering and MBA (finance) both from Rutgers University in NJ.

He is a member of board of directors of Sweden based Cyxone AB. The company is focused on MS and autoimmune diseases and is listed on Nasdaq OMX under the ticker CYXO.